Mammograms are unlikely to benefit older women with increased comorbidity, as they would probably die from something else before they could develop breast cancer. That is what results from a new study on more than [more]
Many cancer drugs undergoing clinical trials kill malignant cells by acting on targets different from the one they were intended to hit. This surprising finding warns against poor preclinical characterization of targets and potential drugs [more]
More than 28,500 participants from 138 countries worldwide pacifically invaded Barcelona, Spain, from September 27 to October 1, attending 299 sessions with 2,218 accepted abstracts and 93 late-breaking abstracts, during the event organized by ESMO [more]
Most cancer drugs introduced since 2004 provide low added value compared to previously approved medications, but have much higher prices, according to a French study presented at the congress of the European Society for Medical Oncology [more]
The ten-year results of the Multicentric Italian Lung Detection (MILD) trial demonstrated that prolonged screening with biennial low-dose computed tomography (LDCT) is safe and effective compared to annual test, leading to a comparable reduction in lung cancer (LC) mortality in subjects with negative baseline LDCT. [more]
The latest developments in the field of lung cancer were discussed last week in Barcelona (Spain) during the 20th edition of the World Conference on Lung Cancer organized by the International Association for the Study of Lung Cancer (IASLC). The focus of clinical studies ranged from screening to treatment of advanced disease. [more]
Stella Kyriakides, a medical psychologist with many years of experience in the field of social affairs, health and cancer prevention, will lead the health portfolio in the new European Commission, according to an announcement by [more]
Cardiovascular disease remains the leading cause of mortality among middle aged adults globally, accounting for 40% of all deaths, but in high-income countries cancer is now responsible for twice as many deaths as CVD (55% vs 23%), according to a new report from the Prospective Urban and Rural Epidemiologic (PURE) study published in The Lancet. [more]
In women diagnosed with first primary breast cancer (BC), a closer look to epigenetic might be the “ace in the hole” to better understand the link between Aspirin use and prognosis and to refine patients stratification and risk-reducing strategies. Findings from a study recently published in Cancer suggest that the [more]
Among young oncologists, women encounter more difficulties than men in attending conferences and this may affect their professional satisfaction. This is the key message of a survey conducted by a group of researchers of the [more]
Labels containing warnings on the health risks associated with alcohol consumption are usually not noticed and remembered by teenagers, who should be in principle among the main targets. According to a study published in the Jou [more]
Launched in late June this year, the 2019 WHO Report “Offer help to quit tobacco use” claims that 5 billion people (65% of the world’s population) are exposed to at least one measure to control the [more]
A new study on the allocation of research funding in the United States concluded that highly deadly cancer types are under-supported. This may be at least partially due to the impact of emotional choices on [more]